renal cell cancer
Showing 1 - 25 of >10,000
Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)
Not yet recruiting
- Advanced Renal Cell Carcinoma
- Botensilimab
- +3 more
- (no location specified)
Jun 23, 2023
Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))
Active, not recruiting
- Renal Cancer
- Dendritic Cell Tumor Fusion Vaccine
- Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 2, 2023
Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))
Active, not recruiting
- Oligoprogressive Renal Cell Carcinoma
- Stereotactic ablative body radiation (SABR)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 28, 2022
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Implementation of Shared Decision Making Strategy for Renal Cell
Recruiting
- Renal Cell Carcinoma
- Renal Cell Carcinoma Metastatic
- Decision aid
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Ziekenhuis
Nov 28, 2022
Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial
Recruiting
- Renal Cancer
- +2 more
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC locatie VUMC
Jan 20, 2023
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 2, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- (no location specified)
May 14, 2023
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte
Recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 19, 2023
Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +11 more
- Cabozantinib S-malate
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)
Withdrawn
- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer
- tivozanib
- therapeutic conventional surgery
- (no location specified)
Aug 11, 2022
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +2 more
- Nivolumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving
Recruiting
- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul
Recruiting
- Urological Malignancies
- +4 more
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Jan 30, 2023
Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,
Completed
- Metastatic Renal Cell Carcinoma
- +4 more
- HyperAcute®-Renal (HAR) Immunotherapy
-
Iowa City, Iowa
- +2 more
Apr 4, 2022
Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 5, 2022
Metastatic Renal Cell Cancer Trial in United States (Axitinib)
Active, not recruiting
- Metastatic Renal Cell Cancer
-
Duarte, California
- +3 more
Jun 1, 2022
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento
Recruiting
- Advanced Colorectal Carcinoma
- +15 more
- Fermented Wheat Germ Extract
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jul 26, 2023
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Cryosurgery
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 6, 2022
Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,
Active, not recruiting
- Kidney Medullary Carcinoma
- +3 more
- Ipilimumab
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- stereotactic body radiation therapy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022